Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Magee AMS"'
Autor:
Dembitz V; Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK.; Department of Physiology and Croatian Institute for Brain Research, University of Zagreb School of Medicine, Zagreb, Croatia., Lawson H; Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK.; The Institute of Cancer Research, London, UK., Burt R; Division of Cell and Molecular Biology, Imperial College London, London, UK.; Francis Crick Institute, London, UK., Natani S; Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK., Philippe C; Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK.; INSERM U1242, University of Rennes, Rennes, France., James SC; Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK., Atkinson S; Division of Cell and Molecular Biology, Imperial College London, London, UK.; Francis Crick Institute, London, UK., Durko J; Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK., Wang LM; Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK.; The Institute of Cancer Research, London, UK., Campos J; Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK.; The Institute of Cancer Research, London, UK., Magee AMS; Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK., Woodley K; Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK., Austin MJ; Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK., Rio-Machin A; Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK.; Experimental Hematology Lab, IIS-Fundación Jimenez Díaz, UAM, Madrid, Spain., Casado P; Centre for Cancer Genomics & Computational Biology, Barts Cancer Institute, Queen Mary University of London, London, UK., Bewicke-Copley F; Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK.; Centre for Cancer Genomics & Computational Biology, Barts Cancer Institute, Queen Mary University of London, London, UK., Rodriguez Blanco G; The University of Edinburgh MRC Institute of Genetics and Cancer, University of Edinburgh, Edinburgh, UK., Pereira-Martins D; Department of Experimental Hematology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., Oudejans L; Department of Experimental Hematology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., Boet E; Centre de Recherches en Cancérologie de Toulouse, Université de Toulouse, Inserm U1037, CNRS U5077, LabEx Toucan, Toulouse, France.; Équipe labellisée Ligue Nationale Contre le Cancer 2023, Toulouse, France., von Kriegsheim A; The University of Edinburgh MRC Institute of Genetics and Cancer, University of Edinburgh, Edinburgh, UK., Schwaller J; University Children's Hospital and Department of Biomedicine (DBM), University of Basel, Basel, Switzerland., Finch AJ; Centre for Tumour Biology, Barts Cancer Institute, Queen Mary University of London, London, UK., Patel B; Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK., Sarry JE; Centre de Recherches en Cancérologie de Toulouse, Université de Toulouse, Inserm U1037, CNRS U5077, LabEx Toucan, Toulouse, France.; Équipe labellisée Ligue Nationale Contre le Cancer 2023, Toulouse, France., Tamburini J; Translational Research Centre in Onco-hematology, Faculty of Medicine, University of Geneva and Swiss Cancer Center Leman, Geneva, Switzerland., Schuringa JJ; Department of Experimental Hematology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., Hazlehurst L; Modulation Therapeutics, Morgantown, WV, USA., Copland Iii JA; Department of Cancer Biology, Mayo Clinic, Jacksonville, FL, USA., Yuneva M; Francis Crick Institute, London, UK., Peck B; Centre for Tumour Biology, Barts Cancer Institute, Queen Mary University of London, London, UK., Cutillas P; Centre for Cancer Genomics & Computational Biology, Barts Cancer Institute, Queen Mary University of London, London, UK., Fitzgibbon J; Centre for Cancer Genomics & Computational Biology, Barts Cancer Institute, Queen Mary University of London, London, UK., Rouault-Pierre K; Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK., Kranc K; Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK.; The Institute of Cancer Research, London, UK., Gallipoli P; Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK. p.gallipoli@qmul.ac.uk.
Publikováno v:
Leukemia [Leukemia] 2024 Aug 26. Date of Electronic Publication: 2024 Aug 26.
Autor:
Woodley K; Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK., Dillingh LS; Wellcome - MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK., Giotopoulos G; Wellcome - MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK.; Department of Haematology, University of Cambridge, Cambridge, UK., Madrigal P; Wellcome - MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK.; Department of Haematology, University of Cambridge, Cambridge, UK.; European Molecular Biology Laboratory, European Bioinformatics Institute, EMBL-EBI, Hinxton, CB10 1SD, UK., Rattigan KM; Wolfson Wohl Cancer Research Centre, Institute of Cancer Sciences, University of Glasgow, Glasgow, UK., Philippe C; Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK., Dembitz V; Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK., Magee AMS; Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK., Asby R; Department of Haematology, University of Cambridge, Cambridge, UK., van de Lagemaat LN; Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK., Mapperley C; Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK., James SC; Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK., Prehn JHM; Department of Physiology & Medical Physics, Royal College of Surgeons in Ireland University of Medicine and Health Sciences, Dublin, Ireland., Tzelepis K; Wellcome - MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK.; Department of Haematology, University of Cambridge, Cambridge, UK.; Milner Therapeutics Institute, University of Cambridge, Cambridge, UK., Rouault-Pierre K; Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK., Vassiliou GS; Wellcome - MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK.; Department of Haematology, University of Cambridge, Cambridge, UK., Kranc KR; Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK., Helgason GV; Wolfson Wohl Cancer Research Centre, Institute of Cancer Sciences, University of Glasgow, Glasgow, UK., Huntly BJP; Wellcome - MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK.; Department of Haematology, University of Cambridge, Cambridge, UK., Gallipoli P; Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK. p.gallipoli@qmul.ac.uk.
Publikováno v:
Nature communications [Nat Commun] 2023 Apr 14; Vol. 14 (1), pp. 2132. Date of Electronic Publication: 2023 Apr 14.